(Q33953275)

30 July 2017

title

Improvement in cholesterol emboli syndrome after iloprost therapy (English)

1 reference

30 July 2017

1

Eran Elinav

1 reference

30 July 2017

Tova Chajek-Shaul

2

1 reference

30 July 2017

Mirella Stern

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

30 July 2017

1 reference

30 July 2017

volume

324

1 reference

30 July 2017

issue

7332

1 reference

30 July 2017

page(s)

268-269

1 reference

Blue toe syndrome. Causes and management

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65057

PubMed Central

reference URL

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65057

PubMed Central

reference URL

After the blue toe: prognosis of noncardiac arterial embolization in the lower extremities.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=65057

PubMed Central

reference URL

29 October 2018

Identifiers

DOI

10.1136/BMJ.324.7332.268

1 reference

30 July 2017

1 reference

30 July 2017

1 reference